{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:00Z","timestamp":1789913640165,"version":"4.0.1"},"reference-count":59,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310977\/2014-2, 404400\/2014-4"],"award-info":[{"award-number":["310977\/2014-2, 404400\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26-201583\/2014, E-26\/111682\/2013, E-26\/102415\/2010, E-26\/201747\/2015"],"award-info":[{"award-number":["E-26-201583\/2014, E-26\/111682\/2013, E-26\/102415\/2010, E-26\/201747\/2015"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00100","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T03:29:10Z","timestamp":1487820550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection"],"prefix":"10.3389","volume":"8","author":[{"given":"Marcus Vin\u00edcius","family":"Alves-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirlei","family":"Nico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Morrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa B.","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"B1","author":"World Health Organization","year":"2016","journal-title":"WHO Report on Global Surveillance of Epidemic-Prone Infectious Diseases \u2013 Leishmaniasis"},{"issue":"5","key":"B2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"B3","first-page":"251","article-title":"T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy","volume":"9","author":"Da-Cruz","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","article-title":"Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review","volume":"99","author":"Silveira","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"8","key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","article-title":"Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis","volume":"31","author":"Silveira","year":"2009","journal-title":"Parasite Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"981686","DOI":"10.1155\/2012\/981686","article-title":"Subversion of immunity by Leishmania amazonensis parasites: possible role of phosphatidylserine as a main regulator","volume":"2012","author":"Mendes Wanderley","year":"2012","journal-title":"J Parasitol Res"},{"issue":"3","key":"B7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/infdis\/jiu455","article-title":"Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis","volume":"211","author":"Fran\u00e7a-Costa","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"B8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"B10","doi-asserted-by":"publisher","first-page":"e0004739","DOI":"10.1371\/journal.pntd.0004739","article-title":"Clinical and parasitological features of patients with American cutaneous leishmaniasis that did not respond to treatment with meglumine antimoniate","volume":"10","author":"Perez-Franco","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"14","key":"B11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years. Review","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"issue":"27","key":"B12","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"issue":"19","key":"B13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec\u00ae vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4601893","DOI":"10.1155\/2016\/4601893","article-title":"Hematological, biochemical, and serological findings in healthy canine blood donors after the administration of CaniLeish\u00ae vaccine","volume":"2016","author":"Starita","year":"2016","journal-title":"Vet Med Int"},{"issue":"22","key":"B15","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"B16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijpara.2006.03.006","article-title":"Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD)","volume":"36","author":"Mauricio","year":"2006","journal-title":"Int J Parasitol"},{"issue":"11","key":"B17","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"9\u201310","key":"B18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"27\u201328","key":"B19","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"15","key":"B20","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1021\/bi702448s","article-title":"Structural basis for substrate specificity in group I nucleoside hydrolases","volume":"47","author":"Iovane","year":"2008","journal-title":"Biochemistry"},{"issue":"6","key":"B21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbapap.2009.02.011","article-title":"Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors","volume":"1794","author":"Vers\u00e9es","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"23\u201324","key":"B22","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/S0264-410X(01)00031-7","article-title":"Vaccination of Balb\/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani","volume":"19","author":"Paraguai de Souza","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"B23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"issue":"22","key":"B24","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1016\/j.vaccine.2006.03.005","article-title":"Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of L. donovani","volume":"24","author":"Gamboa-Le\u00f3n","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.provac.2009.07.019","article-title":"Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis","volume":"1","author":"Borja-Cabrera","year":"2009","journal-title":"Proc Vaccinol"},{"issue":"6","key":"B26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2007.77.1060","article-title":"Protection of susceptible BALB\/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania","volume":"77","author":"Al-Wabel","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.provac.2009.07.022","article-title":"The nucleoside hydrolase DNA vaccine VR1012NH36 in prophylactic vaccination against mice tegumentar leishmaniasis","volume":"1","author":"Souza","year":"2009","journal-title":"Proc Vaccinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2014.00189","article-title":"Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania donovani nucleoside hydrolase terminal domains","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunol"},{"issue":"1\u20132","key":"B31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-1119(01)00768-5","article-title":"A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite","volume":"280","author":"Cui","year":"2001","journal-title":"Gene"},{"key":"B32","volume-title":"Blast-Basic Local Alignment Search Tool","author":"NIH","year":"2016"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1747-0285.2009.00825","article-title":"Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa","volume":"74","author":"Kao","year":"2009","journal-title":"Chem Biol Drug Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front Microbiol"},{"issue":"3","key":"B35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1440-1711.2002.01092.x","article-title":"Immuno-informatics: mining genomes for vaccine components","volume":"80","author":"De Groot","year":"2002","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"B36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev"},{"issue":"7","key":"B37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"B38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine","volume":"7","author":"Palatnik de Sousa","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"B39","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/21645515.2016.1139254","article-title":"Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties","volume":"12","author":"Hudspeth","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pep.2016.10.008","article-title":"Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis","volume":"130","author":"McAtee","year":"2016","journal-title":"Protein Expr Purif"},{"issue":"3","key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"13","key":"B42","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"B43","doi-asserted-by":"publisher","first-page":"e1622","DOI":"10.1371\/journal.pntd.0001622","article-title":"Improved canine and human visceral leishmaniasis immunodiagnosis using combinations of synthetic peptides in enzyme-linked immunosorbent assay","volume":"6","author":"Costa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fimmu.2015.00464","article-title":"Endogenous antigen presentation of MHC class II epitopes through non-autophagic pathways","volume":"6","author":"Leung","year":"2015","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.104","article-title":"Heterogeneity, functional specialization and differentiation of monocyte-derived dendritic cells","author":"Chow","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1038\/emi.2016.86","article-title":"An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene","volume":"5","author":"Sun","year":"2016","journal-title":"Emerg Microbes Infect"},{"issue":"11","key":"B47","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.4049\/jimmunol.174.11.7147","article-title":"CD4 CD25 regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection","volume":"174","author":"Ji","year":"2005","journal-title":"J Immunol"},{"issue":"12","key":"B48","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1089\/jir.2015.0043","article-title":"IFN-\u03b3-dependent recruitment of CD4(+) T cells and macrophages contributes to pathogenesis during Leishmania amazonensis infection","volume":"35","author":"Carneiro","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2017.00227","article-title":"Leishmania donovani-nucleoside hydrolase (NH36) domains induce T-cell cytokine responses in human visceral leishmaniasis","volume":"8","author":"Santos","year":"2017","journal-title":"Front Immunol"},{"issue":"11","key":"B50","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/intimm\/dxl085","article-title":"Novel pan-DR-binding T cell epitopes of adenovirus induce pro-inflammatory cytokines and chemokines in healthy donors","volume":"18","author":"Haveman","year":"2006","journal-title":"Int Immunol"},{"issue":"9","key":"B51","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"issue":"11","key":"B52","doi-asserted-by":"publisher","first-page":"e0142563","DOI":"10.1371\/journal.pone.0142563","article-title":"Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice","volume":"10","author":"Ghaffari-Nazari","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"B53","doi-asserted-by":"publisher","first-page":"e85955","DOI":"10.1172\/jci.insight.85955","article-title":"Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii","volume":"1","author":"El Bissati","year":"2016","journal-title":"JCI Insight"},{"key":"B54","author":"Alexander","year":"1997","journal-title":"Induction of Immune Response against Desired Determinants"},{"issue":"10","key":"B55","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"B56","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"B57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"issue":"10","key":"B58","doi-asserted-by":"publisher","first-page":"e108848","DOI":"10.1371\/journal.pone.0108848","article-title":"Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2\/DR1 transgenic mice: steps toward polytope vaccine","volume":"9","author":"Seyed","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"B59","doi-asserted-by":"publisher","first-page":"e33161","DOI":"10.1371\/journal.pone.0033161","article-title":"Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses","volume":"7","author":"Kedzierska","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T20:37:03Z","timestamp":1568839023000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":59,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00100","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}